Status: Recruiting
Reduced Vaccine Response to HZ/su in SLE
The goal of this observational study is to compare the vaccine response to the 2 doses of the adjuvanted herpes zoster subunit vaccine(HZ/su, "Shingrix") in patients with SLE and the age-, sex-, ethnicity-matched controls without autoimmune disease.
Participants needed: 80
Trial details
Age: 50+Biological sex: AllType: ObservationalSponsor: Seoul National University HospitalUpdated: Jun 9, 2026Locations: 1
Eligibility criteria
Males or females ≥ 50 years of age at time of consent [+12]
Pregnant or lactating females [+5]